Offering BBI’s expertise in the fight against Covid-19

As a worldwide market-leading provider of diagnostic reagents and rapid test/lateral flow contract services, BBI Solutions are dedicated to using our 35 years of expertise to help the fight against COVID-19

We are invested in providing business continuity at a time when our core mission, to 'Serve the Science of Diagnostics', has never been more critical.

At this exceptional time, BBI Solutions can and will help with;

Mobile test capture, interpretation and data dissemination using the Novarum™ mobile diagnostic solution

Novarum™ Mobile Diagnostic Platform

  • Improves the reliability of decentralised rapid testing by reducing user error and subjectivity
  • Enables epidemiological tracing due to data sharing and access
  • Direct communication channel to reinforce safe distancing measures and self-isolation
  • Applicable to all visual PoC platforms– agnostic on test format
Learn more

Capacity for lateral flow test manufacture for immunoassays

Lateral flow test manufactur for immunoassays


  • 120,000 sq. feet for manufacturing; ISO13485:2016 certified QMS system
  • Available for surge manufacture of your Covid-19 antigen or serology assays
  • Relieve capacity in your standard product portfolio manufacture to schedule Covid-19 assay production
  • R&D teams available to assist with validation of tests in development
Learn more

Gold Colloid and Conjugation

BBI is making its world-leading gold and conjugation services available to SARS-Cov-2 lateral flow assay developers at volumes and costs that remove any barriers to the expeditious roll-out of life-saving products

  • Custom Conjugation
  • Off the shelf conjugates
  • 40nm Human anti-IgM and anti-IgG gold conjugates 
  • Manufactured in-house for secure supply
  • Available for sampling today
Browse our conjugates

Critical reagents for rapid test development and production of Covid-19 assays

  • Anti-Human IgM and Anti-IgG antibodies, at scale for secure ongoing supply
  • 40nm Gold-conjugated Anti-IgM and Anti-IgG conjugates – off the shelf and ready to use
  • Industry-proven reagents, already standard in numerous clinical tests in market
  • Ancillary reagents for other critical care test requirements including antibodies and antigens for the diagnostic biomarker for acute inflammation marker, C-Reactive Protein (CRP)
Browse our secondary antibodies

We have compiled a page answering your frequently asked COVID-19 related questions on our website, which we will keep updated as the situation evolves. You can view these here: 

If you have any specific questions our Customer Services team will be happy to help you

Get in touch to see how we can support you in the fight against the global threat of COVID-19



Copyright © 2020 BBI Solutions. All rights reserved. Designed trademarks and brands are the property of their respective owners. BBIUS